Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Oct 11;18(1):472.
doi: 10.1186/s13063-017-2197-8.

Sedation with propofol during ERCP: is the combination with esketamine more effective and safer than with alfentanil? Study protocol for a randomized controlled trial

Susanne Eberl  1 , Lena Koers  1 , Jeanin E van Hooft  2 , Edwin de Jong  3 , Thomas Schneider  3 , Markus W Hollmann  4 , Benedikt Preckel  1
Affiliations
Randomized Controlled Trial

Sedation with propofol during ERCP: is the combination with esketamine more effective and safer than with alfentanil? Study protocol for a randomized controlled trial

Susanne Eberl et al. Trials. .

Abstract

Background: Endoscopic retrograde cholangiopancreatography (ERCP) is a gastrointestinal procedure that requires a relatively motionless patient during the intervention. Deep sedation by intravenous propofol combined with an opioid has recently become the preferred sedation technique. However, when high doses of propofol are used, side effects, namely respiratory depression, may occur. Esketamine has hypnotic, analgesic, and sympathomimetic effects. Our assumption is that a combination of propofol with esketamine reduces the dosage of individual drugs, thereby minimizing sedation side effects while keeping the same satisfaction level of patients and endoscopists.

Methods/design: The study will be performed as a randomized controlled multicenter trial. Patients undergoing ERCP, ≥ 18 years old, with American Society of Anesthesiologists (ASA) classification I-III will be randomized after written informed consent to group K (propofol/esketamine) or to group A (propofol/alfentanil). The primary outcome, reflecting effectiveness of sedation, is the total dose of propofol. Secondary outcome parameters are patients' and endoscopists' satisfaction with the procedure and the number of sedation-related pulmonary and cardiovascular events. Data on sedation-related events are collected by recording of oxygen saturation (SpO2), respiratory rate (RR), end-tidal CO2 (etCO2), heart rate (HR), arrhythmias (electrocardiogram (ECG)), and non-invasive blood pressure (NIBP) measurements. Satisfaction parameters are collected by means of questionnaires before and after the procedure and on the following day.

Discussion: Esketamine is known for its effective anesthetic and analgesic effects maintaining spontaneous breathing and airway reflexes. Due to an increase in sympathetic tone, hypotension and cardiac depression is less common. Unfortunately esketamine is also known for its psychotomimetic effects. We aim to demonstrate that the combination of esketamine with propofol for sedation in patients subjected to ERCP interventions is nevertheless superior to a combination of propofol with an opioid.

Trial registration: Nederland's Trial Register, NTR5486 . Registered on 17 September 2015.

Keywords: ERCP; Esketamine; Procedural sedation; Propofol.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

This trial is conducted in accordance with the protocol and in compliance with the moral, ethical, and scientific principles governing clinical research as set out in the Declaration of Helsinki (1989) and Good Clinical Practice (GCP). It is registered in the Nederland’s Trial Register (NTR5486) (registration date: 17.11.2015). A centralized ethics committee (the Medical Ethics Committee of the Academic Medical Centre, Amsterdam, The Netherlands (NL)) has approved this study for both participating centers: the Academic Medical Center, Amsterdam and the Tjongerschans ziekenhuis, Heerenveen, The Netherlands. The National Authority, the Central Committee on Research Involving Human Subjects (CCMO), performed a marginal review and there were no objections to perform this study (NL53999.018.15).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Schedule of enrollment, intervention, and assessment according to the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) statement
See this image and copyright information in PMC

References

    1. Chainaki IG, Manolaraki MM, Paspatis GA. Deep sedation for endoscopic retrograde cholangiopacreatography. World J Gastrointest Endosc. 2011;3:34–9. doi: 10.4253/wjge.v3.i2.34. - DOI - PMC - PubMed
    1. Mazanikov M. Patient-controlled sedation for endoscopic retrograde cholangiopancreatography. 2013.
    1. Kapoor H. Anaesthesia for endoscopic retrograde cholangiopancreatography. Acta Anaesthesiol Scand. 2011;55:918–26. - PubMed
    1. Hro A, Mann H, Dickersin K, Berlin JA, Dore CJ, Parulekar WR, Summerskill WSM, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D. Research and reporting methods annals of internal medicine SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200–7. doi: 10.7326/0003-4819-158-3-201302050-00583. - DOI - PMC - PubMed
    1. Absalom A, Mason K. Total intravenous anesthesia and target controlled infusions. A Comprehensive Global Anthology. 2017.

Publication types

MeSH terms

LinkOut - more resources